The United States and China are engaged in a competition that will shape far more than the future of medicine. The country that wins the biotechnology race will wield enormous economic influence. Even more than that, this competition poses a national security threat to our very existence. For decades, the United States held an overwhelming advantage, but that lead is now narrowing faster than most policymakers realize.
Learn More
With families still struggling after years of high inflation, “affordability” remains top of mind for policymakers in Washington. But one organization has little credibility on this front: AARP. Formerly known as the American Association of Retired Persons, a more accurate moniker might be Against Affordability for Retired Persons because AARP makes most of its money by overcharging its members. As I outline in a new report for American Commitment, its most recently available financial statement shows…
Learn More
Well, figuratively speaking. Here are the latest findings from ace researcher Chris Jacobs on AARP’s financials: AARP has received an estimated $10.8 billion in tax-free revenue from UnitedHealth since 2007. [That’s BILLION, not million.]; In 2024, AARP received an additional $9.1 billion from UnitedHealth as an advance on future royalty fees tied to AARP-endorsed insurance plans, which AARP expects to recognize over 12 years – equivalent to roughly $755 million in annual royalty revenue; In…
Learn More
Washington, D.C. – July 14, 2026 – Today, as part of its “Commitment to Seniors” initiative, American Commitment released a comprehensive report conducted by Juniper Research Group analyzing the scope and implications of AARP’s multi-billion-dollar financial relationship with UnitedHealth Group, the nation’s largest health insurance company. Key findings include: AARP has received an estimated $10.8 billion in tax-free revenue from UnitedHealth since 2007. In 2024, AARP received an additional $9.1 billion from UnitedHealth as an…
Learn More
After years of rampant expansion into nearly every corner of the health care system, the biggest insurance conglomerates are confronting new efforts to break up their businesses. Arguing that the companies have become too dominant, Arkansas and Tennessee passed laws that aim to prevent the companies from managing prescription benefits and running retail and mail-order pharmacies. Lawmakers in other states and in Washington have proposed similar restrictions. In response, the three companies — UnitedHealth Group,…
Learn More
Following the expiration of the Covid-era enhanced Obamacare subsidies at the end of last year, the corporate media have remained focused on how much Exchange enrollment might decline this year. But a new report issued by the Department of Health and Human Services (HHS) provides another perspective on the issue. Official reports by the Congressional Budget Office and Government Accountability Office have previously examined how applicants misstate their income to qualify for subsidies and how Exchanges permitted enrollment of fictitious applicants. But the data HHS…
Learn More
The developed world has long forced American patients to disproportionately shoulder the cost of pharmaceutical innovation. And President Donald Trump has had enough. He recently put our allies on notice—by launching a formal trade investigation into Germany’s unfair drug pricing practices and signaling his readiness to formally investigate other nations if they refuse to change course. Those investigations are desperately needed. Germany’s government is poised to enact an even more aggressive price-setting scheme in the…
Learn More
The U.S. has launched an investigation into Germany’s pharma policies over what it referred to as “persistent underpayment” for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs. “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,” said U.S. Trade Representative Jamieson Greer in a statement late Thursday. “I am particularly concerned with news that Germany is fast-tracking…
Learn More